Protein Trafficking and Alzheimers Disease
Journal:
Current Alzheimer Research
Volume:
1
Page:
1-10
Author(s):
Kengo Uemura, Akira Kuzuya and Shun Shimohama
The Identification and Characterization of Excitotoxic Nerve-endings in Alzheimer Disease
Journal:
Current Alzheimer Research
Volume:
1
Page:
11-25
Author(s):
Rudi K. Tannenberg, Heather L. Scott, Robert I. Westphalen and Peter R. Dodd
Recent Evidence Regarding a Role for Cdk5 Dysregulation in Alzheimers Disease
Journal:
Current Alzheimer Research
Volume:
1
Page:
33-38
Author(s):
E. A. Monaco III
Involvement of Advanced Glycation End-products (AGEs) in Alzheimers Disease
Journal:
Current Alzheimer Research
Volume:
1
Page:
39-46
Author(s):
Masayoshi Takeuchi, Seiji Kikuchi, Nobuyuki Sasaki, Takako Suzuki, Takayuki Watai, Mina Iwaki, Richard Bucala and Sho-ichi Yamagishi
5-HT1 Receptors
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
1-10
Author(s):
Laurence Lanfumey and Michel Hamon
5-HT2 Receptors
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
11-26
Author(s):
J E Leysen
5-HT3 Receptors
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
27-37
Author(s):
Brenda Costall and Robert J Naylor
5-ht6 Receptors
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
59-79
Author(s):
Marie L Woolley, Charles A Marsden and Kevin C.F Fone
Acetylcholinesterase Inhibition in Alzheimers Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
231-251
Author(s):
Bernd Ibach and Ekkehard Haen
Functional Neurochemistry of Alzheimers Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
265-293
Author(s):
Wieland Gsell, Gerd Jungkunz and Peter Riederer